Text therapy could boost opioid recovery

NCT ID NCT04808479

Completed Disease control Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a text-message-based cognitive behavioral therapy (CBT) program called imFREE to help adults with opioid use disorder stick with their buprenorphine treatment and reduce opioid use. Participants receive daily text messages with CBT skills and relapse prevention tips. The trial compares imFREE to a standard health education program over 32 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: imFREE mCBT (text-message cognitive behavioral therapy)
What this could lead to: If effective, imFREE could offer a low-cost, scalable way to improve medication adherence and reduce opioid use in people with opioid use disorder.
What could go wrong: This is a relatively small, early-stage behavioral trial. The intervention may not work better than standard education, and results may not apply to everyone with opioid use disorder.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE DISORDER

Contacts and locations

Show contact details

Locations

Tarzana Treatment Center

Tarzana, California, 91356, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.